Snowball logo
logo
VIRX

Viracta Therapeutics Inc

VIRX β€’ NASDAQ
$0.00978$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20192020202120222023TTM
Revenue
Total revenue
2.0730.12---0.738
COGS
-0.0320.1780.210.492-
Gross Profit
2.0730.088(0.178)(0.21)(0.492)-
Operating Expenses & Income
Operating Income
(23.29)(18.82)62.5(50.59)(50.69)(47.21)
Total Operating Expenses
25.3618.8225.850.5950.6946.98
R&D Expenses
15.4113.4723.8626.2633.3733.09
Selling General & Admin Expenses
3.1939655.34815.4424.3317.3214.12
Earnings from Continuing Operations
Interest Expense
(0.514)(0.216)(0.491)(0.577)(3.704)(3.183)
Interest Income
0.5140.3020.0381.1713.232.113
Income Tax Expense
0.5140.18288.30.577-(0.477276)
Net Income
Net Income
(23.33)(19.2)(203.1)(49.77)(51.06)(43.29)
Supplemental
EBIT
(22.82)(18.8)(114.3)(50.59)(47.35)(40.11)
EBITDA
(22.81)(18.77)(114.1)(50.38)(46.86)(39.67)
In millions of USD, except % and values per 1 share